// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Altered expression of G-protein coupled receptor 56 (GPR56) is associated with pathological neovascularization during oxygen-induced retinopathy.

Jose Carlos Rivera - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Effects of Lafora disease on the retina of a transgenic mouse model

Melanie C W Campbell - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Auto-fluorescence signals of pure amyloid-β and presumed retinal amyloid deposits

Rachel Redekop - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Histopathological study on the pathogenesis of intratarsal keratinous cyst

Tina Tang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A series of unusual intraocular and orbital metastasis: the importance of immunohistochemistry for the final diagnosis

Ana Beatriz Toledo Dias - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dermatan sulfate

Corneal protein and lipid alterations in response to metallic impaction

Ayman J Aljohani - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluorescein sodium

Inhibition of CREB and its impact on corneal wound healing in vitro and in vivo

Camille Couture - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluorescein sodium

Establishment of optimal culture media in human corneal epithelial wound healing models

Lakshman N Subbaraman - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cataract Surgery Wound Architecture with Manual vs. Femtosecond Laser Assisted Catalys Procedures.

Etienne Benard-Seguin - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Cetirizine dihydrochloride - pseudoephedrine hydrochloride

Contribution of the WNK1 kinase to corneal wound healing using a human tissue-engineered cornea as a model

Pascale Desjardins - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DMSO

Administration of nitric oxide via novel copper-chitosan treatments in human corneal and limbal epithelial cell injury

Vasiliki Tellios - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

The cerebellar oculomotor vermis is involved in reflexive but not tonic vergence adaptation

Ian Erkelens - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Corneal neurotization protects the cornea from corneal ulceration and scarring in a rat model of neurotrophic keratopathy

Kira Antonyshyn - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluorescein sodium

SLC4A11 extracellular Loop 3 in corneal endothelial cell adhesion, FECD pathology and therapeutics

Darpan Malhotra - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Multifocal Electroretinography: An Objective Functional Test for Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity

Adrian C Tsang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Hydroxychloroquine

POEGMA Hydrogels as a Posterior Depot for Controlled Release of Protein-Based Therapeutics

Ben B Muirhead - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluorescein sodium

Pericytes promote capillary constriction in ocular hypertension glaucoma that persists after lowering intraocular pressure

Luis Alarcon-Martinez - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Timolol

MNK1 Inhibition Protects Retinal Ganglion Cells From ERK Mediated Injury

Alessandra Tuccitto - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DMSO

Crystals are not Present in Circulating Cells from CHM Patients

alina radziwon - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

BEST1 gene augmentation therapy corrects light-modulated retinal micro-detachments

Karina E Guziewicz - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved